Method for identifying abundance of cholinesterase in duck plasma and application of related molecular marker
By PCR amplification at specific sites on the duck reference genome, the genotype of ducks can be determined, solving the problem of screening for cholinesterase abundance in duck plasma. This method improves the growth performance and health of meat ducks, reduces breeding costs, and is applicable to Sino-New Zealand white-feathered meat ducks and other duck breeds.
Patent Information
- Application Number
- CN202511631343.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-11-10
- Publication Date
- 2026-07-24
- Estimated Expiration
- 2045-11-10
AI Technical Summary
How can we use genetic breeding techniques to screen key SNP sites that affect the abundance of cholinesterase in duck plasma, apply them to marker-assisted selection, improve the growth performance and health of meat ducks, and meet market demand?
PCR amplification was performed on a DNA fragment at the 3516189th polymorphic site (starting from the 5' end) on chromosome 9 of the duck reference genome IASCAAS_PekinDuck_T2T to determine the CC, CT, and TT genotypes of ducks. Genotype screening was used to influence the abundance of cholinesterase in duck plasma, and molecular marker-assisted selection was performed.
This method enables early screening of cholinesterase abundance in duck plasma, reducing feed waste, lowering breeding costs, and improving selection accuracy. It is suitable for automated detection in large-scale breeding populations and has industrial application value.